A cell-based luminescence assay is effective for high-throughput screening of potential influenza antivirals.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Antiviral Research

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.ANTIVIRAL.2006.07.006PMID 16904762
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Material for Human-Induced Changes in the Hydrology of the Western United States

  2008cited by this paper
• Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States.

  2006cited by this paper
• Oseltamivir resistance in influenza A (H5N1) infection.

  2006cited by this paper
• Community-acquired bacterial meningitis.

  2006cited by this paper
• Pandemics, Avian Influenza A (H5N1), and a Strategy for Pharmacists

  2006cited by this paper
• The Influenza A Virus M2 Cytoplasmic Tail Is Required for Infectious Virus Production and Efficient Genome Packaging

  2005cited by this paper
• [Antivirals for influenza].

  2005cited by this paper
• Improving Consistency of Cell-Based Assays by Using Division-Arrested Cells

  2005cited by this paper
• Cross-Reactive Protection Against Influenza A Virus by a Topically Applied DNA Vaccine Encoding M Gene With Adjuvant

  2005cited by this paper
• Pandemic Influenza: Are We Ready?

  2005cited by this paper
• Use of electric cell-substrate impedance sensing as a tool for quantifying cytopathic effect in influenza A virus infected MDCK cells in real-time.

  2005cited by this paper
• Mechanism of Action of T-705 against Influenza Virus

  2005cited by this paper
• In vitro and in vivo influenza virus-inhibitory effects of viramidine.

  2005cited by this paper
• Quantitative Cell-Based High-Content Screening for Vasopressin Receptor Agonists Using Transfluor®Technology

  2005cited by this paper
• FDA approves Pegasys and Copegus for hepatitis C in patients with HIV co-infection.

  2005cited by this paper
• Cell-based and biochemical screening approaches for the discovery of novel HIV-1 inhibitors.

  2005cited by this paper
• Oseltamivir resistance during treatment of influenza A (H5N1) infection.

  2005cited by this paper
• Evaluation of Division-Arrested Cells for Cell-Based High-Throughput Screening and Profiling

  2005cited by this paper
• Using Visible Spectrophotometers and pH Measurements To Study Speciation in a Guided-Inquiry Laboratory

  2005cited by this paper
• Effect of enamel matrix protein derivative on the attachment, proliferation, and viability of human SaOs2 osteoblasts on titanium implants

  2004cited by this paper
• Resistant influenza A viruses in children treated with oseltamivir: descriptive study.

  2004cited by this paper
• Ribavirin Causes Error Catastrophe during Hantaan Virus Replication

  2003cited by this paper
• Quantitative analysis of influenza virus RNP interaction with RNA cap structures and comparison to human cap binding protein eIF4E.

  2003cited by this paper
• Simple, intuitive calculations of free energy of binding for protein-ligand complexes. 2. Computational titration and pH effects in molecular models of neuraminidase-inhibitor complexes.

  2003cited by this paper
• Treatment of epidemic and pandemic influenza with neuraminidase and M2 proton channel inhibitors.

  2003cited by this paper
• Activation of influenza virus RNA polymerase by the 5' and 3' terminal duplex of genomic RNA.

  2003cited by this paper
• Cellular antiviral responses against influenza A virus are countered at the posttranscriptional level by the viral NS1A protein via its binding to a cellular protein required for the 3' end processing of cellular pre-mRNAS.

  2003cited by this paper
• Assaying Susceptibility of Avian and Other Influenza A Viruses to Zanamivir: Comparison of Fluorescent and Chemiluminescent Neuraminidase Assays

  2003cited by this paper
• Comparison of colorimetric, fluorometric, and visual methods for determining anti-influenza (H1N1 and H3N2) virus activities and toxicities of compounds.

  2002cited by this paper
• Influenza A Virus M2 Ion Channel Activity Is Essential for Efficient Replication in Tissue Culture

  2002cited by this paper
• Role of ATP in influenza virus budding.

  2001cited by this paper
• Characterization of an influenza A (H3N2) virus resistant to the cyclopentane neuraminidase inhibitor RWJ-270201.

  2001cited by this paper
• Broad-Spectrum Antiviral Activity of the IMP Dehydrogenase Inhibitor VX-497: a Comparison with Ribavirin and Demonstration of Antiviral Additivity with Alpha Interferon

  2000cited by this paper
• In vitro and in vivo assay systems for study of influenza virus inhibitors.

  2000cited by this paper
• The broad-spectrum antiviral ribonucleoside ribavirin is an RNA virus mutagen

  2000cited by this paper
• A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays

  1999cited by this paper
• MDCK (Madin-Darby canine kidney) cells: A tool for membrane permeability screening.

  1999cited by this paper
• Characterization of Human Influenza Virus Variants Selected In Vitro in the Presence of the Neuraminidase Inhibitor GS 4071

  1998cited by this paper
• Novel assay for the influenza virus M2 channel activity

  1995cited by this paper
• Inhibition of cap (m7GpppXm)-dependent endonuclease of influenza virus by 4-substituted 2,4-dioxobutanoic acid compounds

  1994cited by this paper
• Rational design of potent sialidase-based inhibitors of influenza virus replication

  1993cited by this paper
• Transport and metabolic functions in cultured renal tubule cells.

  1986cited by this paper
• Evaluation of carbodine, the carbocyclic analog of cytidine, and related carbocyclic analogs of pyrimidine nucleosides for antiviral activity against human influenza Type A viruses

  1981cited by this paper
• Inhibition of Influenza Virus Ribonucleic Acid Polymerase by Ribavirin Triphosphate

  1977cited by this paper
• Resistant influenza A viruses in children treated with oseltamivir : descriptive study

  year unknowncited by this paper

• A High-Throughput Human Tissue Model for Respiratory Viruses: Automating the Use of Human Airway Epithelial Tissues for Faster Drug Discovery.

  2025cites this paper
• High-throughput screening for identification of Influenza A inhibitors using a cell-based immunofluorescence assay.

  2025cites this paper
• A high-throughput response to the SARS-CoV-2 pandemic

  2024cites this paper
• Preventing human influenza and coronaviral mono or coinfection by blocking virus-induced sialylation.

  2024cites this paper
• Factors associated with viral RNA shedding and evaluation of potential viral infectivity at returning to school in influenza outpatients after treatment with baloxavir marboxil and neuraminidase inhibitors during 2013/2014–2019/2020 seasons in Japan: an observational study

  2023cites this paper
• High-Throughput cell-based immunofluorescence assays against influenza

  2023cites this paper
• Novel β-Cyclodextrin-Based Heptavalent Glycyrrhetinic Acid Conjugates: Synthesis, Characterization, and Anti-Influenza Activity

  2022cites this paper
• A Comprehensive Review of Drug Repurposing Strategies against Known Drug Targets of COVID-19

  2022cites this paper
• Quantification of Infectious SARS-CoV-2 by the 50% Tissue Culture Infectious Dose Endpoint Dilution Assay.

  2022cites this paper
• Approaches for discovery of small-molecular antivirals targeting to influenza A virus PB2 subunit.

  2022cites this paper
• Transcriptomes of Clusterin- and S100B-transfected neuronal cells elucidate protective mechanisms against hypoxia and oxidative stress in the hooded seal (Cystophora cristata) brain

  2022cites this paper
• Baloxavir-oseltamivir combination therapy inhibits the emergence of resistant substitutions in influenza A virus PA gene in a mouse model.

  2021cites this paper
• High-Throughput Screening Identifies Inhibitors for Parvovirus B19 Infection of Human Erythroid Progenitors

  2021cites this paper
• Potent antiviral effect of silver nanoparticles on SARS-CoV-2

  2020cites this paper
• The SARS-CoV-2 cytopathic effect is blocked with autophagy modulators

  2020cites this paper
• Identification and Characterization of Novel Compounds with Broad-Spectrum Antiviral Activity against Influenza A and B Viruses

  2020cites this paper
• Protective effects of new aryl sulfone derivatives against radiation-induced hematopoietic injury

  2020cites this paper
• The SARS-CoV-2 Cytopathic Effect Is Blocked by Lysosome Alkalizing Small Molecules

  2020cites this paper
• Cell culture experiments reveal that high S100B and clusterin levels may convey hypoxia-tolerance to the hooded seal (Cystophora cristata) brain.

  2020cites this paper
• Rhodamine B-based fluorescent probes for molecular mechanism study of the anti-influenza activity of pentacyclic triterpenes.

  2020cites this paper
• Design, synthesis of oleanolic acid-saccharide conjugates using click chemistry methodology and study of their anti-influenza activity.

  2019cites this paper
• Screening and evaluation of antiviral compounds against Equid alpha-herpesviruses using an impedance-based cellular assay.

  2019cites this paper
• Structure, function, and evolution of Gga-AvBD11, the archetype of the structural avian-double-β-defensin family

  2019cites this paper
• High-throughput bioassays using "dip-and-go" multiplexed electrospray mass spectrometry.

  2019cites this paper
• Automated cell-based luminescence assay for profiling antiviral compound activity against enteroviruses

  2019cites this paper
• Investigating Different Mechanisms of Action in Combination Therapy for Influenza

  2018cites this paper
• Design, synthesis and biological evaluation of water-soluble per-O-methylated cyclodextrin-C60 conjugates as anti-influenza virus agents.

  2018cites this paper
• Identification of Inhibitory Compounds Against Singapore Grouper Iridovirus Infection by Cell Viability-Based Screening Assay and Droplet Digital PCR

  2018influential citation
• Synthesis and Anti-H5N1 Activity of Substituted Pyridine Glycosides and (Oxadiazolyl)oxymethylpyridine Acyclic C-Nucleoside Analogues

  2018cites this paper
• Inhibition of influenza virus infection by multivalent pentacyclic triterpene-functionalized per-O-methylated cyclodextrin conjugates.

  2017cites this paper
• Design, synthesis and biological evaluation of gentiopicroside derivatives as potential antiviral inhibitors.

  2017cites this paper
• 3,3'-diindolylmethane mitigates total body irradiation-induced hematopoietic injury in mice.

  2016cites this paper
• Design, synthesis and biological evaluation of novel L-ascorbic acid-conjugated pentacyclic triterpene derivatives as potential influenza virus entry inhibitors.

  2016cites this paper
• Pentacyclic triterpenes grafted on CD cores to interfere with influenza virus entry: A dramatic multivalent effect.

  2016cites this paper
• Olig2-Dependent Reciprocal Shift in PDGF and EGF Receptor Signaling Regulates Tumor Phenotype and Mitotic Growth in Malignant Glioma.

  2016cites this paper
• Acoustic Droplet Ejection Applications for High-Throughput Screening of Infectious Agents

  2016cites this paper
• Spiromastilactones: A new class of influenza virus inhibitors from deep-sea fungus.

  2016cites this paper
• In-Vitro Antiviral Activities of Extracts of Plants of The Brazilian Cerrado against the Avian Metapneumovirus (aMPV)

  2015cites this paper
• Recent advances in host–virus interactomics during entry and infection

  2015cites this paper
• Isosteric replacements of the carboxylic acid of drug candidate VX-787: Effect of charge on antiviral potency and kinase activity of azaindole-based influenza PB2 inhibitors.

  2015cites this paper
• Neoechinulin B and its analogues as potential entry inhibitors of influenza viruses, targeting viral hemagglutinin.

  2015cites this paper
• Benzimidazole analogs inhibit respiratory syncytial virus G protein function

  2015influential citation
• In-Vitro Antiviral Activities of Extracts of Plants of The Brazilian Cerrado against the Avian Metapneumovirus (aMPV)

  2015cites this paper
• Adapting High-Throughput Screening Methods and Assays for Biocontainment Laboratories

  2015cites this paper
• Novel Ranking System for Identifying Efficacious Anti-Influenza Virus PB2 Inhibitors

  2015cites this paper
• Discovery of pentacyclic triterpenoids as potential entry inhibitors of influenza viruses.

  2014cites this paper
• Isolation and identification of phase I metabolites of phillyrin in rats.

  2014cites this paper
• A cell-based high-throughput approach to identify inhibitors of influenza A virus

  2014influential citation
• Screening for lead compounds and herbal extracts with potential anti-influenza viral activity.

  2014cites this paper
• A BSL-4 High-Throughput Screen Identifies Sulfonamide Inhibitors of Nipah Virus

  2014cites this paper
• Global Human-Kinase Screening Identifies Therapeutic Host Targets against Influenza

  2014cites this paper
• Lifting the Mask: Identification of New Small Molecule Inhibitors of Uropathogenic Escherichia coli Group 2 Capsule Biogenesis

  2014cites this paper
• Administration of the Resveratrol Analogues Isorhapontigenin and Heyneanol-A Protects Mice Hematopoietic Cells against Irradiation Injuries

  2014cites this paper
• Reverse Genetics as a Tool for Detection of Negative-Stranded RNA Viruses

  2014cites this paper
• Discovery of a novel, first-in-class, orally bioavailable azaindole inhibitor (VX-787) of influenza PB2.

  2014cites this paper
• Preclinical Activity of VX-787, a First-in-Class, Orally Bioavailable Inhibitor of the Influenza Virus Polymerase PB2 Subunit

  2014cites this paper
• Materials and Methods A 549 Cell Culture and Infection with Seasonal Influenza Viruses

  2014cites this paper
• Cell-based flavivirus infection (CFI) assay for the evaluation of dengue antiviral candidates using high-content imaging.

  2014cites this paper
• Patent Evaluation Inhibitors of influenza viruses replication ( WO 2013019828 ) : a patent evaluation

  2013cites this paper
• Antiviral activity of the plant extracts from Thuja orientalis, Aster spathulifolius, and Pinus thunbergii against influenza virus A/PR/8/34.

  2013cites this paper
• Inhibiting TGFβ1 has a protective effect on mouse bone marrow suppression following ionizing radiation exposure in vitro

  2013cites this paper
• Inhibitors of influenza viruses replication: a patent evaluation (WO2013019828)

  2013cites this paper
• New-generation screening assays for the detection of anti-influenza compounds targeting viral and host functions.

  2013cites this paper
• Assays for the identification of novel antivirals against bluetongue virus.

  2013cites this paper
• Screening methods for influenza antiviral drug discovery

  2012cites this paper
• High-Throughput Screening Identifies a Bisphenol Inhibitor of SV40 Large T Antigen ATPase Activity

  2012cites this paper
• A Drug Screening Method Based on the Autophagy Pathway and Studies of the Mechanism of Evodiamine against Influenza A Virus

  2012cites this paper
• Novel Virostatic Agents against Bluetongue Virus

  2012cites this paper
• Bioluminescence and its impact on bioanalysis.

  2011cites this paper
• A High-Throughput Screening Strategy to Overcome Virus Instability

  2011cites this paper
• A Cytopathic Effect-Based High-Throughput Screening Assay Identified Two Novel Compounds that Inhibit Dengue Infection: Streptovitacin A and Nagilactone C

  2011cites this paper
• Development of luminescent sensing systems with clinical applications

  2011cites this paper
• Alanine substitutions within a linker region of the influenza A virus non-structural protein 1 alter its subcellular localization and attenuate virus replication.

  2011cites this paper
• Development of a high-throughput human rhinovirus infectivity cell-based assay for identifying antiviral compounds.

  2011cites this paper
• Assessing the In Vitro Fitness of an Oseltamivir-Resistant Seasonal A/H1N1 Influenza Strain Using a Mathematical Model

  2011cites this paper
• Discovery of Novel Benzoquinazolinones and Thiazoloimidazoles, Inhibitors of Influenza H5N1 and H1N1 Viruses, from a Cell-Based High-Throughput Screen

  2011cites this paper
• A novel cell-based 384-well, label-free assay for discovery of inhibitors of influenza A virus

  2010cites this paper
• Identification of small-molecule inhibitors of ricin and shiga toxin using a cell-based high-throughput screen.

  2010influential citation
• Development of a high-throughput cell based 384-well influenza A quantification assay for interpandemic and highly pathogenic avian strains.

  2010cites this paper
• Pyrazole compound BPR1P0034 with potent and selective anti-influenza virus activity

  2010cites this paper
• IMPROVING THE EXPERIMENTAL CHARACTERIZATION OF ANTI-INFLUENZA DRUG EFFICACY USING MATHEMATICAL MODELS

  2010cites this paper
• A Facile Synthesis and Anti-Avian Influenza Virus (H5N1) Screening of Some Novel Pyrazolopyrimidine Nucleoside Derivatives

  2010cites this paper
• HTS-Driven Discovery of New Chemotypes with West Nile Virus Inhibitory Activity

  2010cites this paper
• Researchcompound BPR1P0034 with potent and selective anti-influenza virus activity

  2010cites this paper
• High-throughput screening using pseudotyped lentiviral particles: a strategy for the identification of HIV-1 inhibitors in a cell-based assay.

  2009cites this paper
• Assay development and high-throughput antiviral drug screening against Bluetongue virus

  2009cites this paper
• The development, optimization and validation of an assay for high throughput antiviral drug screening against Dengue virus.

  2009cites this paper
• Influenza virus assays based on virus‐inducible reporter cell lines

  2009cites this paper
• Drug Development Research

  2009cites this paper
• The Use of Reverse Genetics to Clone and Rescue Infectious, Recombinant Human Parainfluenza Type 3 Viruses

  2009cites this paper
• A recombinant, infectious human parainfluenza virus type 3 expressing the enhanced green fluorescent protein for use in high-throughput antiviral assays.

  2008cites this paper
• Identification and Characterization of Compounds with Antiviral Activity against Influenza Viruses

  2008influential citation
• High-Throughput Screening of a 100,000-Compound Library for Inhibitors of Influenza A Virus (H3N2)

  2008cites this paper
• Modulation of influenza virus replication by alteration of sodium ion transport and protein kinase C activity

  2008cites this paper
• Cell-based assays to identify inhibitors of viral disease

  2008cites this paper
• Adapting Cell-Based Assays to the High-Throughput Screening Platform: Problems Encountered and Lessons Learned

  2008cites this paper
• An improved embryonated chicken egg model for the evaluation of antiviral drugs against influenza A virus.

  2008cites this paper
• Development of a high-throughput Alamar blue assay for the determination of influenza virus infectious dose, serum antivirus neutralization titer and virus ca/ts phenotype.

  2008cites this paper
• Nippostrongylus brasiliensis: reversibility of reduced-energy status associated with the course of expulsion from the small intestine in rats.

  2007cites this paper
• NIAID resources for developing new therapies for severe viral infections

  2007cites this paper